Close×

German filling and packaging technology manufacturer Krones has purchased a 60 per cent stake in a global intralogistics solutions provider for the beverage industry.

Krones has successfully closed the transaction and acquired a majority stake in System Logistics.

The deal was pending customary anti-trust approval, and approval has now been granted.

System Logistics is known for its large automated plants which are set up for intralogistics in beverages.

Intralogistics involves optimising, integrating, automating, and managing the logistical flow of information and material goods.

“The interest coming from Krones represents for us a meaningful recognition that reveals the human and intellectual heritage of System Logistics SpA, making the company a strategic partner for the German Group,” System's president Franco Stefani said.

“We believe in the primary role of innovation, and are open to international markets in order to combine high technology with human heritage.”

In other news, Krones' cycling bottle has won an A’Design award in the Packaging Design category.

The sports bottle consists of stable PET, and can be reused.

kr11

The digital Krones DecoType inkjet system applies ink in a direct-print method onto the bottle, which enables the realisation of structures which could not be processed before now.

The direct-print method enables a wider variety of eye-catching designs.

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.